The fight against cervical cancer in Nigeria has found one of its most compelling advocates in Amb. Dr. (Mrs.) Franca Ajeborsi Eze, a Stage II cervical cancer survivor who has turned her personal medical struggle into a systemic campaign for public health. As the President and Founder of the My Body My Asset Cancer Foundation, Eze has spent the last decade navigating the complex landscape of oncology advocacy, bridging the gap between clinical healthcare and community outreach. Her work comes at a critical juncture for Nigeria, where cervical cancer remains the second most frequent cancer among women and the second most frequent cause of cancer death among women between the ages of 15 and 44.

A Personal Catalyst for Public Change

The origin of the My Body My Asset Cancer Foundation is rooted in the narrative of early detection. Ten years ago, a routine cervical screening led to a Stage II diagnosis for Eze. Her survival, which she attributes directly to the efficacy of early intervention and subsequent HPV vaccination, provided the blueprint for her foundation’s core philosophy.

Eze’s advocacy is characterized by a pragmatic approach to the barriers that define the Nigerian oncology experience. She identifies a complex web of deterrents: ingrained social stigma, economic hardship, and the prevalence of "sick care"—a cultural tendency to seek medical attention only when the disease has reached an advanced, symptomatic stage. Her own experience with stigma, particularly an incident at Yaba Market where she was disparaged for her condition, did not deter her; instead, it emboldened her to adopt the disparaging label as a brand identity, effectively neutralizing its power to silence survivors.

The Landscape of Cervical Cancer in Nigeria

Cervical cancer is largely preventable, yet the statistical reality in Nigeria remains sobering. According to data from the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC), Nigeria records over 12,000 new cases of cervical cancer annually, with approximately 8,000 deaths resulting from the disease. The primary driver of these malignancies is the Human Papillomavirus (HPV).

The introduction of the HPV vaccine into the national routine immunization schedule is a milestone in public health. However, the efficacy of this policy is contingent upon public uptake. For decades, the lack of awareness regarding the link between HPV and cervical cancer allowed the disease to progress silently across rural and underserved populations. The My Body My Asset Cancer Foundation has responded by decentralizing awareness efforts, moving beyond urban centers into markets, churches, mosques, and schools.

Chronology of Advocacy and Outreach

The foundation’s operational timeline highlights a shift from basic awareness to strategic community engagement:

• 2016–2018 (Formative Years): The foundation established its footing by focusing on direct patient support and the dissemination of basic diagnostic information.
• 2019–2022 (Expansion): The initiative scaled its operations, partnering with media outlets and healthcare providers to demystify cancer treatment and address the financial barriers that often prevent women from completing chemotherapy or radiation cycles.
• 2023–2026 (Strategic Diversification): Recent initiatives have included the integration of multilingual outreach. In January 2026, the foundation’s successful campaign in the Oyi Local Government Area of Anambra State underscored the critical role of linguistic accessibility. By communicating directly in Igbo, Ezza, and Idoma, the foundation significantly increased local participation in screening programs, proving that cultural nuance is a prerequisite for medical success in Nigeria.

The Multi-Sectoral Approach to Prevention

Amb. Eze argues that the eradication of cervical cancer is not a task for the healthcare sector alone. It requires a collaborative framework involving the government, the private sector, and educational institutions.

Government and Policy Requirements

The government’s primary role is to ensure the consistent availability and affordability of the HPV vaccine. Furthermore, the development of mobile screening clinics is essential to reach populations that lack the transportation or financial stability to visit specialized oncology centers. Policy-makers are increasingly urged to treat cervical cancer screening as a standard component of primary healthcare rather than an elective service.

The Role of Corporate Responsibility

Corporate entities in Nigeria are positioned to play a vital role through structured Corporate Social Responsibility (CSR) programs. Rather than one-off donations, the model championed by the My Body My Asset Cancer Foundation encourages companies to treat cancer prevention as a strategic investment. This includes sponsoring mass vaccination drives, subsidizing diagnostic costs for low-income populations, and implementing mandatory health education within their own corporate structures.

Educational Integration

Integrating reproductive health and HPV awareness into school curricula serves as a long-term preventive strategy. By educating the younger generation, the foundation aims to erase the stigma associated with the vaccine, viewing it as a routine health safeguard rather than a controversial intervention.

Socio-Economic Implications of Cancer Advocacy

The ripple effect of a cancer diagnosis in Nigeria extends far beyond the physical toll on the patient. It often precipitates a total collapse of a family’s financial stability. The "financial toxicity" of cancer care—the out-of-pocket costs for diagnostic tests, surgery, and palliative care—is a leading cause of poverty in many households.

Advocacy groups like the one led by Eze serve as a buffer, providing not only navigation support but also direct financial subsidies. By collaborating with hospitals to negotiate reduced costs for screening and treatment, these groups are effectively lowering the threshold for entry into the healthcare system. The broader implication is a more robust, informed, and resilient population that views health as an asset to be protected through consistent, preventive action.

Future Outlook and Expert Consensus

Medical experts and public health officials generally concur with the foundation’s focus on the "prevention-first" paradigm. While advancements in targeted therapy and immunotherapy have improved survival rates for late-stage patients, the cost-benefit analysis overwhelmingly favors early screening and vaccination.

The current trajectory of cancer advocacy in Nigeria suggests a transition toward data-driven, community-based interventions. The success of the My Body My Asset Cancer Foundation serves as a model for how non-governmental organizations (NGOs) can fill systemic gaps. However, the long-term sustainability of these efforts depends on the codification of these practices into national health policy.

For the newly diagnosed, Amb. Eze’s message remains consistent: the diagnosis is not an end, but a call to action. Her survival, coupled with her commitment to ensuring others have the same access to life-saving information, illustrates the power of patient-led advocacy. As the nation moves toward the goal of eliminating cervical cancer, the integration of survivor-led voices with clinical, governmental, and corporate support will be the defining factor in determining the success of these public health initiatives.

Conclusion

The evolution of cancer advocacy in Nigeria reflects a broader maturation of the nation’s healthcare discourse. By moving from a culture of silence and fear to one of proactive, informed engagement, foundations like the My Body My Asset Cancer Foundation are changing the narrative. The path forward is clear: sustained investment in HPV vaccination, the decentralization of diagnostic services to reach rural areas, and the continued empowerment of survivors to serve as ambassadors for health. Through these efforts, the dream of a Nigeria where cervical cancer is no longer a leading cause of death becomes an achievable reality rather than a distant goal.